CN102600420A - Medicine composition for blood stasis and qi stagnation - Google Patents
Medicine composition for blood stasis and qi stagnation Download PDFInfo
- Publication number
- CN102600420A CN102600420A CN2012101036976A CN201210103697A CN102600420A CN 102600420 A CN102600420 A CN 102600420A CN 2012101036976 A CN2012101036976 A CN 2012101036976A CN 201210103697 A CN201210103697 A CN 201210103697A CN 102600420 A CN102600420 A CN 102600420A
- Authority
- CN
- China
- Prior art keywords
- stagnation
- blood
- blood stasis
- medicine composition
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine composition for blood stasis and qi stagnation. The medicine composition is characterized by being composed of the following raw materials: salvia miltiorrhiza, borneol, rhizoma corydalis, santalum album and fructus amomi.
Description
One, technical field
The present invention relates to one group of stagnation of QI and blood drug regimen.
Two, summary of the invention:
Be to provide one group of stagnation of QI and blood drug regimen, to overcome the deficiency of known technology order of the present invention.
The present invention is achieved in that one group of stagnation of QI and blood drug regimen, and its special character is that it is to be processed by following raw materials in part by weight: Radix Salviae Miltiorrhizae 3000 grams, Borneolum Syntheticum 15 grams, Rhizoma Corydalis 1000 grams, Lignum Santali Albi 500 grams, Fructus Amomi 600 grams.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature.GUIXIN, pericardium, Liver Channel.Blood circulation promoting and blood stasis dispelling is arranged, removing heat from blood eliminating carbuncle, the relieving restlessness effect of calming the nerves.
Rhizoma Corydalis: acrid in the mouth, hardship, warm in nature.Return liver, spleen channel.Pain relieving is arranged, the promoting the circulation of QI effect of invigorating blood circulation.
Borneolum Syntheticum: acrid in the mouth, hardship, cold nature.GUIXIN, spleen, lung meridian.Have and have one's ideas straightened out, the clearing away heat to alleviate pain effect.
Lignum Santali Albi: acrid in the mouth, warm in nature.Return spleen, stomach, lung meridian.Promoting the circulation of QI to relieve pain are arranged, effect during cold expelling is transferred.
Fructus Amomi: acrid in the mouth, warm in nature.Return spleen, stomach, kidney channel.The removing dampness warming middle-JIAO is arranged, circulation of qi promoting, antidiarrheal efficacy.
Three, technical background:
Function: blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain.
Cure mainly: stagnation of QI and blood, all pains of heart stomach disease.
Modern Application: chronic gastritis, gastric and duodenal ulcers, nervus gastrica palace ability disease belong to qi depression to blood stasis person.Coronary heart disease, angina pectoris, chronic hepatitis, chronic pancreatitis etc.
The side separates: we cure mainly all pain cards of heart stomach.Its pathogenesis is that stagnation of QI and blood is tied in heart stomach mutually, and stagnation of QI and blood may bring about pain is so with blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain are method.Reuse Radix Salviae Miltiorrhizae in the side, blood circulation promoting and blood stasis dispelling is a monarch drug, and the promoting the circulation of QI pain relieving of invigorating blood circulation of Rhizoma Corydalis principal drug assistance is ministerial drug.Lignum Santali Albi, Fructus Amomi promoting the circulation of QI to alleviate the stagnation in middle-JIAO, Borneolum Syntheticum are had one's ideas straightened out clearing away heat to alleviate pain altogether for adjuvant drug.The invigorating middle warmer of Radix Glycyrrhizae QI invigorating, all medicines of blending are messenger drug, and five medicines share, and QI and blood is unobstructed, and then pain is played blood circulation promoting and blood stasis dispelling, the merit of promoting the circulation of QI to relieve pain altogether from ending.Make the state of an illness effectively treated and cure.
Four, the specific embodiment:
Below in conjunction with the specific embodiment, the present invention is further specified.
The specific embodiment: get Radix Salviae Miltiorrhizae 3000 grams, Rhizoma Corydalis 1000 grams, Lignum Santali Albi 500 grams install with cloth bag, put into liquid multifunctional vacuum thickener and are condensed into paste, are put in the oven dry of Low-temp. electrothermal vacuum drier again, can make to concentrate dried medicine piece 500-600 gram.Put into Fructus Amomi 500 grams under 160 ° of-200 ° of high temperature of microwave drying sterilization machine, operate 3-5 minute, sterilizing, drying is made substrate; With Borneolum Syntheticum 15 grams; Add to concentrate to do again and want piece to put refrigerator together freezing 6 hours, be processed into fine powder with totally-enclosed pulverizer, the reuse Autocapsulefillingmachine is processed capsule; Every heavy 0.6 gram capsule, it is subsequent use to bottle.
Method for using: be grown up one day 3 times, after meal the 3-4 grain.3 of the each clothes of body weight 50-65 kilogram, each clothes are 4 more than 65 kilograms.
By every kg body weight 0.1 gram feeding white mice, once a day, feeding is 30 days continuously with these article, and the white mice physiological function is normal, and inspection white mice organ dysfunction is not found any unusual.
Points for attention: contraindication in pregnancy.The careful usefulness of drug allergy person is arranged.
Taboo: stiff food, the careful usefulness of drinks.
King's car woods, the man, 36 years old, suffer from chronic gastritis, take one group of stagnation of QI and blood drug regimen capsule, one day three times, take 4 after meal half an hour, take a course of treatment continuously and recover.
Wang Yumei, the woman, 31 years old, Deficiency and coldness of spleen and stomach was taken one group of stagnation of QI and blood drug regimen capsule, and one day three times, 3 after meal, take a course of treatment continuously and take a turn for the better, take a course of treatment again and cure.
Jiang Yuhua, the woman, 39 years old, suffer from chronic gastritis, take one group of stagnation of QI and blood drug regimen capsule, one day 3 times, 3 after meal, take 2 courses of treatment continuously and recover.
Li Chengyi, the man, 41 years old, suffer from coronary heart disease, one group of stagnation of QI and blood drug regimen capsule is taken in angina pectoris, one day 3 times, 3 after meal, take one the course of treatment transference cure, take 2 courses of treatment continuously and recover.
Claims (1)
1. one group of stagnation of QI and blood drug regimen is characterized in that it is made up of following weight portion: Radix Salviae Miltiorrhizae 3-6 part, Rhizoma Corydalis 1-3 part, Lignum Santali Albi 0.5-1 part, Fructus Amomi 0.5-1 part, 0.02 part-0.03 part of Borneolum Syntheticum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101036976A CN102600420A (en) | 2012-04-01 | 2012-04-01 | Medicine composition for blood stasis and qi stagnation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101036976A CN102600420A (en) | 2012-04-01 | 2012-04-01 | Medicine composition for blood stasis and qi stagnation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102600420A true CN102600420A (en) | 2012-07-25 |
Family
ID=46518439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101036976A Pending CN102600420A (en) | 2012-04-01 | 2012-04-01 | Medicine composition for blood stasis and qi stagnation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600420A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208556A (en) * | 2014-08-20 | 2014-12-17 | 王彩云 | Traditional Chinese medicine capsule for treating blood-stasis qi-stagnation syndrome and preparation method thereof |
| CN104689241A (en) * | 2015-03-18 | 2015-06-10 | 付连进 | Medicine for treating Qi-stagnation and blood stasis type coronary heart disease and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087272A (en) * | 1992-11-28 | 1994-06-01 | 河南省中药研究所 | A kind of Chinese powder medicine capsule that is used for the treatment of chronic ischemic heart disease |
| CN1539474A (en) * | 2003-10-28 | 2004-10-27 | 济南宏济堂制药有限责任公司 | Drug for treating coronary heart disease, angina and preparation method |
| CN101085011A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Composition containing corydalis tuber for treating cardiovascular diseases and its preparation |
| CN101204559A (en) * | 2007-11-29 | 2008-06-25 | 北京中科雍和医药技术有限公司 | Medicaments composite for coronary heart disease, angina and epigastralgia and preparation method thereof |
| WO2010035262A2 (en) * | 2008-09-25 | 2010-04-01 | Life Biotech Medical Research Ltd | Herbal formulations |
| EP2415749A1 (en) * | 2009-03-30 | 2012-02-08 | Tianjin Tasly Pharmaceutical Co. Ltd. | New salvianolic acid compound l, preparation method and use thereof |
-
2012
- 2012-04-01 CN CN2012101036976A patent/CN102600420A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087272A (en) * | 1992-11-28 | 1994-06-01 | 河南省中药研究所 | A kind of Chinese powder medicine capsule that is used for the treatment of chronic ischemic heart disease |
| CN1539474A (en) * | 2003-10-28 | 2004-10-27 | 济南宏济堂制药有限责任公司 | Drug for treating coronary heart disease, angina and preparation method |
| CN101085011A (en) * | 2006-06-08 | 2007-12-12 | 天津天士力制药股份有限公司 | Composition containing corydalis tuber for treating cardiovascular diseases and its preparation |
| CN101204559A (en) * | 2007-11-29 | 2008-06-25 | 北京中科雍和医药技术有限公司 | Medicaments composite for coronary heart disease, angina and epigastralgia and preparation method thereof |
| WO2010035262A2 (en) * | 2008-09-25 | 2010-04-01 | Life Biotech Medical Research Ltd | Herbal formulations |
| EP2415749A1 (en) * | 2009-03-30 | 2012-02-08 | Tianjin Tasly Pharmaceutical Co. Ltd. | New salvianolic acid compound l, preparation method and use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 于广莹: "丹参饮临床应用举隅", 《中国中医急症》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208556A (en) * | 2014-08-20 | 2014-12-17 | 王彩云 | Traditional Chinese medicine capsule for treating blood-stasis qi-stagnation syndrome and preparation method thereof |
| CN104689241A (en) * | 2015-03-18 | 2015-06-10 | 付连进 | Medicine for treating Qi-stagnation and blood stasis type coronary heart disease and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872431A (en) | Capsules for treating deficiency-cold in spleen and stomach | |
| CN102697949A (en) | Qi-blood replenishing tablet | |
| CN102641468A (en) | Group of medicine composition for strengthening spleen and stomach | |
| CN102988485A (en) | Tablets for warming phlegm and retained fluid and removing dampness through diuresis | |
| CN102847007A (en) | Dandelion fritillaria phlegm reduction tablets | |
| CN103100060A (en) | A group of Scutellaria baicalensis and Gentian tablets used for eliminating fire | |
| CN102600420A (en) | Medicine composition for blood stasis and qi stagnation | |
| CN102526658A (en) | Chinese patent medicine for treating liver stagnation and spleen deficiency | |
| CN102716287A (en) | Qi depressing and asthma relieving capsule set | |
| CN102716452A (en) | Group of channel warming and coldness expelling tablet | |
| CN102772761A (en) | Tablets for removing heat to cool blood and soothing liver-qi stagnation | |
| CN102973873A (en) | Three kernel removing dampness tablets | |
| CN102872308A (en) | Snake gourd fruit tablets for promoting circulation of qi and removing stasis | |
| CN102772555A (en) | Golden flower detoxicatcating tablet | |
| CN102716236A (en) | Qi benefiting and superficies syndrome relieving tablet set | |
| CN102671173A (en) | Medicine compound tablet for infant splenoasthenic diarrhea | |
| CN102772769A (en) | Medicinal tablet for warming middle-Jiao, tonifying deficiency and strengthening spleen | |
| CN102716264A (en) | Medicinal compound tablet for warming channel and expelling cold | |
| CN102846820A (en) | Wind-cold treatment tablet | |
| CN102872318A (en) | Fritillary and trichosanthes capsule | |
| CN102847114A (en) | Ephedra and fresh ginger drug tablets for treating affection of exotenous wind-cold | |
| CN102861168A (en) | Astragalus mongholicus Yin-astringing tablet | |
| CN102772629A (en) | Tablet for soothing nerves and relieving restlessness | |
| CN102846718A (en) | Cold tablet for dispelling cold | |
| CN102716460A (en) | Evil-expelling and depression-resolving combined tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120725 |